Lipocine (LPCN) P/E (2013 - 2026)
Lipocine (LPCN) P/E from Oct 22, 2013 to Jul 21, 2026. The TTM Lipocine (LPCN) P/E is -1.17. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Lipocine (LPCN)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.17 | -74.81% |
| 2025 | -4.64 | -100.38% |
| 2024 | 1.23K | -136922.24% |
| 2023 | -0.90 | -110.53% |
| 2022 | 8.54 | -106.25% |
| 2021 | -136.67 | +3462.61% |
| 2020 | -3.84 | +377.89% |
| 2019 | -0.80 | -66.32% |
| 2018 | -2.38 | -35.46% |
| 2017 | -3.69 | +13.55% |
| 2016 | -3.25 | -73.15% |
| 2015 | -12.11 | +267.36% |
| 2014 | -3.30 | -42.36% |
| 2013 | -5.72 | N/A |
Comparison Lipocine (LPCN) P/E with competitors
Lipocine (LPCN) P/E is -1.17.